Literature DB >> 16880389

Monitoring the T cell response to genital tract infection.

Nadia R Roan1, Todd M Gierahn, Darren E Higgins, Michael N Starnbach.   

Abstract

To date, it has not been possible to study antigen-specific T cell responses during primary infection of the genital tract. The low frequency of pathogen-specific T cells in a naïve mouse makes it difficult to monitor the initial events after antigen encounter. We developed a system to examine the response of pathogen-specific T cells in the genital mucosa after intrauterine infection. We identified the protective CD4(+) T cell antigen Cta1 from Chlamydia trachomatis and generated T cell receptor (TCR) transgenic (tg) mice with specificity for this protein. By transferring TCR tg T cells into naïve animals, we determined that Chlamydia-specific T cells were activated and proliferated in the lymph nodes draining the genital tract after primary intrauterine infection. Activated T cells migrated into the genital mucosa and secreted IFN-gamma. The development of Chlamydia-specific TCR tg mice provides an approach for dissecting how pathogen-specific T cells function in the genital tract.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16880389      PMCID: PMC1567698          DOI: 10.1073/pnas.0603866103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

2.  Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo.

Authors:  R A Hawkins; R G Rank; K A Kelly
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 3.  Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cell for the study of T-cell activation in vivo.

Authors:  K A Pape; E R Kearney; A Khoruts; A Mondino; R Merica; Z M Chen; E Ingulli; J White; J G Johnson; M K Jenkins
Journal:  Immunol Rev       Date:  1997-04       Impact factor: 12.988

Review 4.  Viruses and T cell turnover: evidence for bystander proliferation.

Authors:  D F Tough; J Sprent
Journal:  Immunol Rev       Date:  1996-04       Impact factor: 12.988

5.  Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells.

Authors:  S G Morrison; R P Morrison
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.

Authors:  K H Ramsey; T W Cotter; R D Salyer; G S Miranpuri; M A Yanez; C E Poulsen; J L DeWolfe; G I Byrne
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

7.  Antigen recognition in the female reproductive tract: I. Uptake of intraluminal protein tracers in the mouse vagina.

Authors:  M B Parr; E L Parr
Journal:  J Reprod Immunol       Date:  1990-04       Impact factor: 4.054

8.  Induction of alloreactive cytotoxic T cells by acute virus infection of mice.

Authors:  H Yang; R M Welsh
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

Review 9.  Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis.

Authors:  W L Beatty; R P Morrison; G I Byrne
Journal:  Microbiol Rev       Date:  1994-12

Review 10.  Persistent Chlamydiae and chronic arthritis.

Authors:  Cheryl Villareal; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Arthritis Res       Date:  2001-10-08
View more
  31 in total

1.  Immunization with a combination of integral chlamydial antigens and a defined secreted protein induces robust immunity against genital chlamydial challenge.

Authors:  Weidang Li; Ashlesh K Murthy; M Neal Guentzel; James P Chambers; Thomas G Forsthuber; J Seshu; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

2.  Integrin α4β1 is necessary for CD4+ T cell-mediated protection against genital Chlamydia trachomatis infection.

Authors:  Sergio J Davila; Andrew J Olive; Michael N Starnbach
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

3.  T cell responses in the absence of IFN-gamma exacerbate uterine infection with Chlamydia trachomatis.

Authors:  David C Gondek; Nadia R Roan; Michael N Starnbach
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

4.  Early Colonization of the Upper Genital Tract by Chlamydia muridarum Is Associated with Enhanced Inflammation Later in Infection.

Authors:  Jennifer D Helble; Nicole V Reinhold-Larsson; Michael N Starnbach
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

5.  Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T cells.

Authors:  Saurabh Dixit; Rajnish Sahu; Richa Verma; Skyla Duncan; Guillermo H Giambartolomei; Shree R Singh; Vida A Dennis
Journal:  Biomaterials       Date:  2017-12-26       Impact factor: 12.479

Review 6.  Diversity in the T cell response to Chlamydia-sum are better than one.

Authors:  Jasmine C Labuda; Stephen J McSorley
Journal:  Immunol Lett       Date:  2018-09-01       Impact factor: 3.685

7.  A Chlamydia trachomatis Strain Expressing Ovalbumin Stimulates an Antigen-Specific CD4+ T Cell Response in Mice.

Authors:  Jennifer D Helble; Michael N Starnbach
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

8.  A Chlamydia-Specific TCR-Transgenic Mouse Demonstrates Th1 Polyfunctionality with Enhanced Effector Function.

Authors:  Taylor B Poston; Yanyan Qu; Jenna Girardi; Catherine M O'Connell; Lauren C Frazer; Ali N Russell; McKensie Wall; Uma M Nagarajan; Toni Darville
Journal:  J Immunol       Date:  2017-08-30       Impact factor: 5.422

9.  Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection.

Authors:  Nicolas Cuburu; Mi-Na Kweon; Catherine Hervouet; Hye-Ran Cha; Yuk-Ying S Pang; Jan Holmgren; Konrad Stadler; John T Schiller; Fabienne Anjuère; Cecil Czerkinsky
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications.

Authors:  James S Testa; Ramila Philip
Journal:  Future Virol       Date:  2012-11-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.